Atlas Trials

Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment

Clinical trial NCT07565948 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07565948
Sponsor
Xiangya Hospital of Central South University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Hepatitis C Virus (HCV)
Start date
2022-01-01
Primary completion
2027-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.